Portland, OR, Nov. 17, 2020 (GLOBE NEWSWIRE) -- According to the report, the global Breast Cancer Liquid Biopsy Market generated $87,641 thousand in 2019, and is expected to garner $ 336,659 thousand by 2027, registering a CAGR of 18.3% from 2019 to 2027. The report provides a comprehensive analysis of the changing market dynamics, top investment pockets, key segments, value chain, and competitive scenario.
Download Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/7983?reqfor=covid
Increase in demand for safe and non-invasive procedures, rise in prevalence of breast cancer, and benefits associated with breast cancer liquid biopsy tests over traditional tests proliferate the growth of the global breast cancer liquid biopsy market. On the other hand, lack of access and awareness in underdeveloped countries restrains the growth to certain extent. Nevertheless, high growth potential in emerging markets anticipates to usher an array of new opportunities in the near future.
Covid-19 Scenario:
- The covid-19 outbreak affected the manufacturing and distribution companies in the breast cancer liquid biopsy industry.
- The prolonged lockdowns, on the other hand, disrupted the supply chain processes.
The global breast cancer liquid biopsy market is segmented on the basis of product & service, circulating biomarker, application, and region. Based on product and service, the reagent kit segment contributed to the largest market share in 2019, accounting for nearly three-fourths of the global market, and will continue its dominance throughout the forecast period. Furthermore, the same segment is expected to grow the largest CAGR of 19.4% from 2020 to 2027. The report also involves instruments and services
Based on application, the diagnostics segment held the highest market share in 2019, accounting for more than half of the global market, and is projected to maintain its leadership position throughout the forecast period. On the other hand, the segment is also expected to showcase the fastest CAGR of 19.5% from 2020 to 2027. Other segments studied in the report include prognostics and risk assessment.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/7983
Based on region, North America held the lion’s share in 2019, accounting for more than two-fifths of the global market, and will maintain its dominance throughout 2027. At the same time, this region is estimated to manifest the fastest CAGR of 5.6% during the forecast period. The report also studies market across other regions including LAMEA, Asia-Pacific, and Europe.
The key players profiled in this report include Biocept, Inc., F. Hoffmann-La Roche Ltd. (Foundation Medicine, Inc.), Fluxion Biosciences, Inc., Menarini Group (Menarini Silicon Biosystems, Inc.), Myriad Genetics, Inc., NeoGenomics Laboratories, Inc., Qiagen N.V., Sysmex Corporation, and Thermo Fisher Scientific Inc.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Similar Reports:
Breast Pumps Market - Global Opportunity Analysis and Industry Forecast, 2020–2027
Breast Imaging Technologies Market - Global Opportunity Analysis and Industry Forecast, 2019-2027
Breast Biopsy Market - Global Opportunity Analysis and Industry Forecast, 2019-2027
Breast Imaging Equipment Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
Breast Implants Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
Breast Feeding Aid Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.